Syndecan-1, His, Human
Syndecan-1, His, Human

Immobilized Syndecan-1, His, Human, His Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-Syndecan-1 Antibody, hFc Tag with the EC50 of 23.2ng/ml determined by ELISA.

Syndecan-1, His, Human

Syndecan-1, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

Syndecan-1, His, Human

Liver diseases such as liver cirrhosis, primary and metastatic liver cancers are still a major medical challenge. Syndecan-1 is one of the most important proteoglycans in the liver. Syndecan-1 is normally expressed on the surfaces of hepatocytes and cholangiocytes. Due to liver diseases the amount of syndecan-1 increases in the liver.
Z05859
¥72,752.00

Ask us a question
Product Introduction
Species Human
Protein Construction
Syndecan-1 (Gln23-Gly254)_x000D_
Accession # AAH08765		 His
N-term C-term
Purity > 95% as determined by Bis-Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 25 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 50-80 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • Syndecan-1, His, Human
    • Syndecan-1, His, Human

    Immobilized Syndecan-1, His, Human, His Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-Syndecan-1 Antibody, hFc Tag with the EC50 of 23.2ng/ml determined by ELISA.

  • Syndecan-1, His, Human
    • Syndecan-1, His, Human

    Syndecan-1, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background Liver diseases such as liver cirrhosis, primary and metastatic liver cancers are still a major medical challenge. Syndecan-1 is one of the most important proteoglycans in the liver. Syndecan-1 is normally expressed on the surfaces of hepatocytes and cholangiocytes. Due to liver diseases the amount of syndecan-1 increases in the liver.
Synonyms Syndecan-1; SYND1; CD138; SDC1; SDC; SDC1

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.